Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 19, 2010

View Archived Issues

Preclinical and clinical data presented on antibiotic CB-183315

Lundbeck describes new neuropeptide Y5 receptor antagonists

U.S. scientists claim new MAPK 8 inhibitors

MorphoSys and Proteros Biostructures receive grant to develop new technology platform

Biotie regains rights to phosphodiesterase 10 inhibitors for CNS disorders

Phase I data reported on Zealand Pharma's ZP-1848 in Crohn's disease

Phase I trials assess safety, tolerability and pharmacokinetics of ASM-024

DCVax-L is well tolerated combined with other anticancer agents in ovarian cancer

PEGylated opioid analgesic NKTR-181 demonstrates slowed entry into CNS

Tekmira receives grant to develop RNAi agents against Ebola and Marburg virus infections

Genmab reports feedback from U.S. and E.U. authorities on zalutumumab

EC grants orphan drug status for pralatrexate in Hodgkin's lymphoma

Labopharm and Paladin Labs enter agreements on pain medications

Amgen reviews TREAT data and proposes updates to ESA labeling

New protein kinase inhibitors identified by sanofi-aventis

FDA approves ISTA's sNDA for bromfenac ophthalmic solution Bromday

Inhibitex completes enrollment in phase II FV-100 trial in shingles

New inhibitors of dual specificity protein kinase TTK claimed

Glenmark Pharmaceuticals patents new TRPA1 modulators

FDA approves Botox as treatment for chronic migraine

Celgene acquires Abraxis BioScience

EMA grants orphan drug status for forodesine in chronic lymphocytic leukemia

Phosphagenics to advance TPM oxycodone patch

New selective serine/threonine-protein kinase 6 inhibitors discovered

Levetiracetam does not improve cerebellar symptoms of multiple sclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...